Multiple sclerosis and Retinal vein thrombosis

Summary:

Retinal vein thrombosis is found among people with Multiple sclerosis, especially for people who are female, 50-59 old.

The study analyzes which people have Retinal vein thrombosis with Multiple sclerosis. It is created by eHealthMe based on reports of 23 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,086 drugs and 1,365 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.

What is Retinal vein thrombosis?

Retinal vein thrombosis (clot formation in small veins that carry blood away from the retina) is found to be associated with 99 drugs and 255 conditions by eHealthMe. Check the latest studies of Retinal vein thrombosis.



On Aug, 08, 2026

23 people who have Multiple Sclerosis and Retinal Vein Thrombosis are studied.

Would you have Retinal vein thrombosis when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experienced Retinal Vein Thrombosis *:

  • female: 77.27 %
  • male: 22.73 %

Age of people who have Multiple Sclerosis and experienced Retinal Vein Thrombosis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 5.5600000000000005 %
  • 30-39: 5.5600000000000005 %
  • 40-49: 38.89 %
  • 50-59: 38.89 %
  • 60+: 11.11 %

Common co-existing conditions for these people *:

  1. Depression: 8 people, 34.78%
  2. Herpes Simplex (herpes simplex is a common viral infection): 3 people, 13.04%
  3. Neurogenic Bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion): 2 people, 8.70%
  4. High Blood Pressure: 2 people, 8.70%
  5. Type 1 Diabetes: 1 person, 4.35%
  6. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 4.35%
  7. Gastritis Erosive (a break in the surface layer of the membrane lining the stomach with infection): 1 person, 4.35%
  8. Breast Cancer: 1 person, 4.35%
  9. Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 4.35%

Common drugs taken by these people *:

  1. Escitalopram: 8 people, 34.78%
  2. Gilenya: 5 people, 21.74%
  3. Rebif: 5 people, 21.74%
  4. Aspirin: 4 people, 17.39%
  5. Valtrex: 3 people, 13.04%
  6. Lioresal: 2 people, 8.70%
  7. Tysabri: 2 people, 8.70%
  8. Avonex: 1 person, 4.35%
  9. Campral: 1 person, 4.35%
  10. Copaxone: 1 person, 4.35%

Common symptoms for these people *:

  1. Visual Acuity Reduced (reduced clearness of vision): 9 people, 39.13%
  2. Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 5 people, 21.74%
  3. Retinal Haemorrhage (bleeding from retina): 3 people, 13.04%
  4. Blindness Unilateral: 2 people, 8.70%
  5. High Blood Pressure: 2 people, 8.70%
  6. Injection Site Swelling: 1 person, 4.35%
  7. Eye Oedema (swelling or thickening of the macula, the area of the retina responsible for central vision): 1 person, 4.35%
  8. Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 4.35%
  9. Injection Site Erythema (redness at injection site): 1 person, 4.35%
  10. Injection Site Mass: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Retinal vein thrombosis?

- Check whether Retinal vein thrombosis is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Retinal vein thrombosis:

All the conditions that are associated with Retinal vein thrombosis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Retinal vein thrombosis and Multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: